Heat Biologics Inc (NASDAQ:HTBX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - HTBX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - HTBX

  • Market Cap$186.800m
  • SymbolNASDAQ:HTBX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS42237K3005

Company Profile

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells that secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector.Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient’s immune system against cancer utilizing an engineered form of gp96.

Latest HTBX news

Currently there for this company. Visit our news hub for other news .